The potential to develop MPA in MPO-ANCA-positive patients was observed not only in those with the initial IPF diagnosis but also in those with non-IPF, and that this risk was independently associated with UIP pattern on HRCT and the absence of treatment for IIP. This evidence concerns the gene MPO and idiopathic pulmonary fibrosis.